Said Differently Merges with Brainvire; Stellus Provides Unitranche Financing

Falfurrias Capital Partners Invests in Said Differently

September 8, 2022

Marketing & Advertising

Falfurrias Capital Partners made a platform investment in Said Differently, a virtual marketing agency that assembles integrated teams of specialists from a global network to deliver strategic consulting, design and development services. The investment (terms undisclosed) is the fourth from Falfurrias' Fund V and supports the firm's "Future of Work" thesis; Alexander Jutkowitz will join Said Differently as Executive Chairman.

BV Investment Partners Invests in Hardenbergh Group; Stellus Provides Unitranche Financing

August 15, 2023

Healthcare Services

BV Investment Partners made a growth-oriented investment in The Hardenbergh Group, a provider of non-clinical professional staffing, consulting, physician peer review and outsourced GRC solutions to healthcare organizations. Stellus Capital Management provided unitranche senior debt financing and an equity co-investment to support BV's investment; proceeds will fund Hardenbergh's strategic growth plan and expansion of its GRC and staffing capabilities.

Interlock Equity and Stellus Capital Invest in evolv Consulting

January 22, 2024

Data & Analytics

Los Angeles-based private equity firm Interlock Equity has made a strategic growth investment in evolv Consulting, a Dallas-based data-driven management and technology consultancy. Stellus Capital Management provided unitranche financing and an equity co-invest to support the transaction; the capital will be used to expand evolv's services, deepen industry expertise, broaden geographic reach and enable strategic add-ons.

Thoma Bravo and Madison Dearborn Partners Complete Investments in Syntellis Performance Solutions

August 3, 2020

Software

Funds affiliated with private equity firms Thoma Bravo and Madison Dearborn Partners completed investments in Syntellis Performance Solutions, enabling the company to operate as a standalone, software-focused business. The transaction provides capital and resources to accelerate product innovation, expand client services, and support growth across healthcare, higher education and financial institution markets.

Norstella and Citeline Merge to Create $5B Global Pharma Technology Company

June 28, 2022

Data & Analytics

Norstella (the group of Evaluate, MMIT, Panalgo and The Dedham Group) announced an agreement to merge with Citeline (formerly Pharma Intelligence) to form a combined global pharmaceutical technology and intelligence business valued at about $5 billion. The combination brings clinical trial intelligence, commercial data and real‑world analytics together to offer an end‑to‑end suite of solutions for life sciences companies; the deal involves financial sponsors including Hg (Norstella) and Warburg Pincus (Citeline).

Recognize Partners (with Stellus financing) Makes Strategic Growth Investment in 2X

March 29, 2023

Marketing & Advertising

Recognize Partners made a strategic growth equity investment in 2X, the B2B marketing-as-a-service (MaaS) pioneer, marking 2X's first institutional financing. Stellus Capital Management provided unitranche debt and an equity co-investment to support the transaction; 2X's management team will remain in place to scale the firm's MarTech, delivery, and global capabilities.